-- TTX-MC138 targets MicroRNA10b for treatment of metastatic disease; TransCode on track to submit exploratory investigational new drug (eIND) application in Q1 2022 -- BOSTON--(BUSINESS ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results